Patrys Ltd Sustainability Reports
Patrys Limited is a clinical-stage biopharmaceutical company focused on the development of its Deoxymab platform of cell-penetrating antibodies as therapies for a range of cancers. It also develops proprietary injectable therapeutic formulations targeting immune-mediated inflammatory diseases and conditions like delirium.
Sector: Manufacturing
Country: Australia
Exchange: Australian Securities Exchange
FIGI: BBG001SNQ2X7
9 reports from 2016 to 2024
